<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: world health organisation</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Sharing anonymized hospital data prevents violence</title>
   	 <description>Combining information from hospitals and police can prevent violence and make communities safer, according to a study published in the British Medical Journal today.</description>
	  <link>http://medicalxpress.com/news/2011-06-anonymized-hospital-violence.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 17 Jun 2011 03:56:13 EST</pubDate>
	 <guid isPermaLink="false">news227501761</guid>
	 
</item>
<item>
     <title>Helping the aged during natural disasters</title>
   	 <description>When earthquake, tsunami, tornado or flood strike, among the most vulnerable group are the elderly. Writing in the International Journal of Emergency Management, researchers in New Zealand suggest that emergency response plans must take into account the age-related needs of adults with regards to the personal and social resources they have available.</description>
	  <link>http://medicalxpress.com/news/2011-06-aged-natural-disasters.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 03 Jun 2011 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news226317363</guid>
	 
</item>
<item>
     <title>Study finds copper proves effective against new E. coli strains</title>
   	 <description>As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak &amp;#150; O104:H4 &amp;#150; laboratory science conducted at the University of Southampton indicates a role for copper in preventing the spread of such infections.</description>
	  <link>http://medicalxpress.com/news/2011-06-copper-effective-coli-strains.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 02 Jun 2011 13:27:20 EST</pubDate>
	 <guid isPermaLink="false">news226240026</guid>
	 
</item>
<item>
     <title>Clinical trial of malaria vaccine begins in Africa</title>
   	 <description>The vaccine, RTS,S, developed by GlaxoSmithKline (GSK) Biologicals and PATH Malaria Vaccine Initiative (MVI), is currently in phase III clinical trials and has previously reduced episodes of malaria in infants and young children by more than 50%.  The Liverpool team, in collaboration with the University College of Medicine, Malawi, are working in Blantyre over the next three years to investigate how to maximise its effectiveness when delivered through the childhood immunisation programme.</description>
	  <link>http://medicalxpress.com/news/2011-05-clinical-trial-malaria-vaccine-africa.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 25 May 2011 10:55:23 EST</pubDate>
	 <guid isPermaLink="false">news225539712</guid>
	 
</item>
<item>
     <title>Major malaria study leads WHO to revise treatment guidelines</title>
   	 <description>The results of the largest ever clinical trial among patients hospitalised with severe malaria - the Wellcome Trust-funded AQUAMAT study - have led the World Health Organisation (WHO) to revise its guidelines for the treatment of the disease in African children.</description>
	  <link>http://medicalxpress.com/news/2011-04-major-malaria-treatment-guidelines.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 27 Apr 2011 06:10:08 EST</pubDate>
	 <guid isPermaLink="false">news223101151</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/majormalaria.jpg" width="90" height="90" />
</item>


</channel>
</rss>
